Barclays Forecasts Strong Price Appreciation for Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International (NYSE:MTD) had its price objective boosted by equities research analysts at Barclays from $1,575.00 to $1,700.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s target price indicates a potential upside of 10.54% from the stock’s previous close.

A number of other analysts also recently issued reports on the company. Morgan Stanley lifted their price target on Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. Royal Bank Of Canada started coverage on Mettler-Toledo International in a research report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 target price on the stock. Weiss Ratings upgraded Mettler-Toledo International from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, September 8th. Stifel Nicolaus upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Finally, Rothschild & Co Redburn started coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 2nd. They issued a “sell” rating and a $1,200.00 price target on the stock. Five research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $1,459.54.

Mettler-Toledo International Stock Up 0.3%

NYSE MTD traded up $4.86 on Wednesday, hitting $1,537.93. 42,816 shares of the stock were exchanged, compared to its average volume of 180,294. Mettler-Toledo International has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,585.72. The company has a 50-day moving average price of $1,416.38 and a 200-day moving average price of $1,295.27. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. The company has a market cap of $30.82 billion, a PE ratio of 34.56, a PEG ratio of 3.09 and a beta of 1.19.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $10.09 earnings per share. Sell-side analysts anticipate that Mettler-Toledo International will post 47.35 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 942 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the completion of the transaction, the chief executive officer directly owned 4,480 shares in the company, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo International stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the transaction, the chief financial officer owned 5,579 shares of the company’s stock, valued at approximately $7,989,128. The trade was a 28.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,254 shares of company stock valued at $6,092,712 in the last quarter. Insiders own 0.71% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently bought and sold shares of MTD. Congress Asset Management Co. purchased a new stake in shares of Mettler-Toledo International in the third quarter valued at $213,000. Andra AP fonden increased its position in Mettler-Toledo International by 125.6% during the 2nd quarter. Andra AP fonden now owns 9,123 shares of the medical instruments supplier’s stock worth $11,655,000 after purchasing an additional 5,080 shares in the last quarter. Reynders McVeigh Capital Management LLC raised its stake in Mettler-Toledo International by 9.2% in the 2nd quarter. Reynders McVeigh Capital Management LLC now owns 827 shares of the medical instruments supplier’s stock valued at $1,057,000 after purchasing an additional 70 shares during the last quarter. National Pension Service raised its stake in Mettler-Toledo International by 7.9% in the 2nd quarter. National Pension Service now owns 39,696 shares of the medical instruments supplier’s stock valued at $50,712,000 after purchasing an additional 2,916 shares during the last quarter. Finally, WINTON GROUP Ltd lifted its holdings in Mettler-Toledo International by 509.0% in the 2nd quarter. WINTON GROUP Ltd now owns 4,141 shares of the medical instruments supplier’s stock valued at $5,290,000 after purchasing an additional 3,461 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer of precision instruments and related services used in laboratory, industrial, food processing, pharmaceutical and retail applications. The company’s solutions help customers measure, analyze, inspect and control materials and products throughout research, manufacturing and distribution processes.

Its product portfolio includes laboratory balances and scales, analytical instruments, automated chemistry systems, titrators, density and refractometry equipment, process analytics, industrial weighing systems, product inspection technologies and retail weighing and labeling solutions.